Affymax (AFFY +15.65%) after announcing that its partner, Takeda Pharmaceuticals, has signed an...

|By:, SA News Editor

Affymax (AFFY +15.65%) after announcing that its partner, Takeda Pharmaceuticals, has signed an agreement to supply their anemia treatment Omontys to U.S. dialysis centers run by Germany's Fresenius Medical Care. Fresenius (FMS -2.1%) intends to initially use the drug in 100 centers before expanding the program. (PR)